Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.

Children who experience recurrent C. diff infections may have fecal inflammatory markers that could predict risk and improve management of these infections.

Two brain signaling pathways have overlapping functions in regulating anxiety, suggesting that therapeutics aimed at one or the other will impact both.

Vanderbilt investigators have identified an unexpected link between cell survival and the polarized delivery of proteins to the surface of mammary epithelial cells.

Vanderbilt investigators are probing the response to a bacterial toxin as a clinical assessment of immune function.

Medicaid expansion under the Affordable Care Act provides patients with a greater choice of hospital facilities, Vanderbilt researchers have found.